- Docente: Emanuel Raschi
- Credits: 2
- SSD: BIO/14
- Language: Italian
- Teaching Mode: Traditional lectures
- Campus: Ravenna
- Corso: Single cycle degree programme (LMCU) in Medicine and Surgery (cod. 5906)
-
from May 15, 2025 to May 28, 2025
Learning outcomes
At the end of this course students know: - the regulatory framework of medicinal products and other products with health claims (food supplements) - the basic rules for appropriate prescribing - drug prescription regulatory framework in the National Health System - key elements in the evaluation of benefit/risk and cost/benefit assessment - clinical trials of medicinal products - sources of information on medicinal products - key variables in drug prescription
Course contents
- The clinical development of a new medicinal product (from phase I to phase IV); requirements and criteria for regulatory approval of a new medicinal product
- Access to drug therapy by citizens: prescribing rules, OTC medicinal products
- Reimbursement of medicinal products by the National Health Service
- Monitoring pharmacotherapy for efficacy and safety (pharmacovigilance)
- Sources of information on medicinal products: value and limitations of evidence-based medicine in pharmacotherapy
- Evaluation of the risk/benefit balance of a medicinal product
- Factors determining variability in drug response; drug interactions
Readings/Bibliography
Please, see the section in Italian
Teaching methods
Interactive sessions
Assessment methods
Oral examination to assess achievement of the learning outcomes (see the Italian version for details)
Teaching tools
Teaching material can be downloaded from the institutional repository (access restricted to UNIBO students).
Office hours
See the website of Emanuel Raschi
SDGs


This teaching activity contributes to the achievement of the Sustainable Development Goals of the UN 2030 Agenda.